BIAF bioAffinity Technologies, Inc. - Common Stock
BIAF Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
BIAF Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
BIAF Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
- Strong Buy 0 0.0%
- Buy 0 0.0%
- Hold 3 50.0%
- Sell 1 16.7%
- Strong Sell 2 33.3%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| Sept. 30, 2025 | $-4.74 | $-2.75 | -2.0% |
| June 30, 2025 | $-5.10 | $-3.06 | -2.0% |
| March 31, 2025 | $-4.80 | $-4.90 | 0.10% |
| Dec. 31, 2024 | $-6.30 | $-4.28 | -2.0% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| BIAF | — | — | — | — | — | — |
| RNAZ | — | -0.1 | — | — | — | — |
| ONCO | $2M | -0.1 | -67.7% | -1721.0% | -129.5% | 77.6% |
| GRI | $122.9K | -0.0 | — | — | -256.3% | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 20 filers · $743K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 11 (+5 vs prior Q) | 4 (+1 vs prior Q) | 4 (+3 vs prior Q) | 1 (-1 vs prior Q) | +626K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | $296,905 | 365,647 | 39.94% | Shares |
| J. Safra Sarasin Holding AG | $164,010 | 42,600 | 22.06% | Shares |
| BlackRock, Inc. | $80,207 | 98,777 | 10.79% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $45,101 | 55,543 | 6.07% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $33,732 | 41,543 | 4.54% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $25,230 | 31,071 | 3.39% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $21,818 | 26,870 | 2.93% | Shares |
| STATE STREET CORP | $19,558 | 24,086 | 2.63% | Shares |
| Sheaff Brock Investment Advisors, LLC | $13,971 | 53,734 | 1.88% | Shares |
| JANE STREET GROUP, LLC | $13,812 | 17,010 | 1.86% | Shares |
| NORTHERN TRUST CORP | $13,599 | 16,748 | 1.83% | Shares |
| Allworth Financial LP | $8,120 | 10,000 | 1.09% | Shares |
| Tower Research Capital LLC (TRC) | $5,263 | 6,482 | 0.71% | Shares |
| ROYAL BANK OF CANADA | $1,000 | 931 | 0.13% | Shares |
| IFP Advisors, Inc | $676 | 833 | 0.09% | Shares |
| UBS Group AG | $345 | 425 | 0.05% | Shares |
| HRT FINANCIAL LP | $16 | 20,834 | 0.00% | Shares |
| Virtu Financial LLC | $9 | 11,113 | 0.00% | Shares |
| MORGAN STANLEY | $2 | 3 | 0.00% | Shares |
| EMC Capital Management | $1 | 2,001 | 0.00% | Shares |
ETF ownership Held by 2 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.